Celestica Recognized as One of Canada’s Top Employers for Young People for the Second Consecutive Year

(TSX:CLS),(NYSE:CLS), TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, is proud to announce that it has been named one of Canada's Top Employers for Young People for 2025 by Mediacorp Canada Inc. This marks […]

Alico, Inc. to Present at Sidoti Micro-Cap Virtual Conference

(NASDAQ:ALCO), FORT MYERS, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Conference, taking place on January 22nd and 23rd of 2025. The presentation

Worksport Ltd. ($WKSP) Announces Strong Q4 2024 Results, Beating Revenue Guidance; Recording a Substantial December Gross Margin increase

(NASDAQ:WKSP), Company Reports Unaudited Quarterly Revenue of $2.93 Million, Year-End Revenue Beat, Top-Line of $8.5 Million; Expects Further Expansion with New Products and Growing Margins West Seneca, New York, Jan. 21, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based manufacturer and innovator of hybrid and clean energy solutions

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham

(NasdaqGM:PRE), The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health CHARLOTTE, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) — IM8, a premium supplements brand co-founded by David Beckham, hosted its U.S. unveiling event in New

Vemanti Group Announces Discussions Regarding Onus Finance UAB

(Other OTC:VMNT),(OTC US:VMNT), IRVINE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT) today announced ongoing discussions aimed at acquiring a majority control of the parent company of Onus Finance UAB (“Onus Finance”), the operator of the innovative cryptocurrency exchange platform, ONUS Pro (https//goonus.io). This strategic move aligns

HYCU(R) R-Cloud(TM) Named to TechTarget Storage Products of the Year Awards

Boston, Massachusetts, Jan. 21, 2025 (GLOBE NEWSWIRE) — HYCU, Inc., a leader for modern data protection for on-prem, cloud services, and SaaS, and one of the fastest growing companies in the industry, announced that HYCU(R) R-Cloud(TM) won Bronze in the Backup and Disaster Recovery Hardware Software and Services Category in the 23rd Annual Awards edition

NewtekOne, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025, After the Market Closes

(NasdaqGM:NEWT), BOCA RATON, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — NewtekOne, Inc. (“the Company”) (NASDAQ: NEWT) announced today that it will report its fourth quarter and full year 2024 financial results after the market closes on Wednesday, February 26, 2025. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive

D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, today announced it has secured significant strategic investments from an institutional investor and ARC Group, a leading global investment bank and management consultancy firm. These partnerships position D. Boral Capital for accelerated growth

Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing

(OTCQB:NBIO),(OTC US:NBIO), NORTH PALM BEACH, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) — Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology company developing monoclonal antibodies targeting various cancer types, today announced that it has received a written notification from the OTC Markets Group as a result of its failure to file

Scroll to Top